Fundamental Analysis of PHREESIA INC(NYSE:PHR) stock

Fundamental Rating

Overall PHR gets a fundamental rating of 3 out of 10. We evaluated PHR against 40 industry peers in the Health Care Technology industry. The financial health of PHR is average, but there are quite some concerns on its profitability. PHR is valied quite expensively at the moment, while it does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

PHR had negative earnings in the past year.

PHR had a negative operating cash flow in the past year.

In the past 5 years PHR always reported negative net income.

In multiple years PHR reported negative operating cash flow during the last 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -36.96%, PHR is in line with its industry, outperforming 48.72% of the companies in the same industry.

PHR has a Return On Equity (-54.44%) which is comparable to the rest of the industry.

		Industry Rank	Sector Rank
ROA	-36.96%
ROE	-54.44%
ROIC	N/A

ROA(3y)-36.15%

ROA(5y)-34.87%

ROE(3y)-47.98%

ROE(5y)-48.8%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

PHR has a Gross Margin (65.19%) which is comparable to the rest of the industry.

In the last couple of years the Gross Margin of PHR has remained more or less at the same level.

PHR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	65.19%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y0.22%

GM growth 5Y0.7%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

PHR does not have a ROIC to compare to the WACC, probably because it is not profitable.

PHR has more shares outstanding than it did 1 year ago.

Compared to 5 years ago, PHR has more shares outstanding

Compared to 1 year ago, PHR has a worse debt to assets ratio.

2.2 Solvency

PHR has an Altman-Z score of 3.55. This indicates that PHR is financially healthy and has little risk of bankruptcy at the moment.

PHR has a better Altman-Z score (3.55) than 79.49% of its industry peers.

PHR has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.

PHR's Debt to Equity ratio of 0.02 is fine compared to the rest of the industry. PHR outperforms 66.67% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.02
Debt/FCF	N/A
Altman-Z	3.55

ROIC/WACCN/A

WACC10.54%

2.3 Liquidity

A Current Ratio of 1.78 indicates that PHR should not have too much problems paying its short term obligations.

Looking at the Current ratio, with a value of 1.78, PHR is in line with its industry, outperforming 48.72% of the companies in the same industry.

A Quick Ratio of 1.78 indicates that PHR should not have too much problems paying its short term obligations.

With a Quick ratio value of 1.78, PHR perfoms like the industry average, outperforming 48.72% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	1.78
Quick Ratio	1.78

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 47.09% over the past year.

Looking at the last year, PHR shows a very strong growth in Revenue. The Revenue has grown by 26.84%.

Measured over the past years, PHR shows a very strong growth in Revenue. The Revenue has been growing by 28.96% on average per year.

EPS 1Y (TTM)47.09%

EPS 3YN/A

EPS 5YN/A

EPS growth Q2Q51.16%

Revenue 1Y (TTM)26.84%

Revenue growth 3Y33.81%

Revenue growth 5Y28.96%

Revenue growth Q2Q24.04%

3.2 Future

Based on estimates for the next years, PHR will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.43% on average per year.

The Revenue is expected to grow by 19.37% on average over the next years. This is quite good.

EPS Next Y-24.14%

EPS Next 2Y7.91%

EPS Next 3Y11.43%

EPS Next 5YN/A

Revenue Next Year22.63%

Revenue Next 2Y20.49%

Revenue Next 3Y19.37%

Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PHR. In the last year negative earnings were reported.

Also next year PHR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y7.91%

EPS Next 3Y11.43%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for PHR!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

PHREESIA INC

NYSE:PHR (5/3/2024, 7:12:13 PM)

After market: 22.32 0 (0%)

22.32

+0.06 (+0.27%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Technology

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap1.26B

Analysts

Price Target

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-36.96%
ROE	-54.44%
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	65.19%
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.96

Health

		Industry Rank	Sector Rank
Debt/Equity	0.02
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	1.78
Quick Ratio	1.78
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)47.09%

EPS 3YN/A

EPS 5Y

EPS growth Q2Q

EPS Next Y-24.14%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)26.84%

Revenue growth 3Y33.81%

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

PHREESIA INC (PHR)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens